Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
MedTech
Boston Scientific plans to make ground despite tariff headwinds
Boston Scientific believes it can absorb the hit based on the continuing growth of its franchises in cardiology and urology.
Conor Hale
Apr 24, 2025 12:15pm
Large trial reveals link between lowered BP and dementia risk
Apr 24, 2025 11:33am
Intuitive posts strong 1Q earnings as tariffs squeeze margins
Apr 23, 2025 11:00am
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
Apr 18, 2025 7:40am
J&J estimates $400M impact from tariffs, largely in medtech
Apr 15, 2025 2:00pm
PacBio to cut headcount, costs in face of tariff headwinds
Apr 9, 2025 11:30am
